Evolent Health (EVH) Gross Profit (2015 - 2026)

Evolent Health's Gross Profit history runs 12 years deep, the most recent figure standing at $83.8 million for Q1 2026.

• In Q1 2026, Gross Profit fell 18.25% year-over-year to $83.8 million; the TTM figure through Mar 2026 stood at $381.2 million (up 4.23% YoY), while the FY2025 annual figure was $399.9 million, up 8.86% from the prior year.
• Gross Profit was $83.8 million for Q1 2026 at Evolent Health, down from $97.3 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $124.4 million in Q3 2023 to a low of $70.2 million in Q2 2022.
• Historically, Gross Profit has averaged $95.8 million across 5 years, with a median of $99.8 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Gross Profit soared 66.87% in 2023, then tumbled 35.15% in 2024.
• A 5-year view of Gross Profit shows it stood at $83.1 million in 2022, then gained by 22.35% to $101.6 million in 2023, then retreated by 25.5% to $75.7 million in 2024, then rose by 28.45% to $97.3 million in 2025, then decreased by 13.86% to $83.8 million in 2026.
• The last three Gross Profit figures came in at $83.8 million (Q1 2026), $97.3 million (Q4 2025), and $99.8 million (Q3 2025), per Business Quant data.